Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04564716
Recruitment Status : Active, not recruiting
First Posted : September 25, 2020
Last Update Posted : December 2, 2020
Russian Direct Investment Fund
CRO: iPharma
Information provided by (Responsible Party):
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 28, 2021
Estimated Study Completion Date : April 10, 2021